Adults whose fasting blood sugar level is within normal to edge range (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases).
Conditions
Interventions
None listed
Sponsors
FUJIFILM Corporation
Yakujihou Marketing Jimusho Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A systematic literature search is performed through scientific and clinical trial registries databases. The selection criteria are as follows. P-Participant: Adults whose fasting blood sugar level is within normal to edge range (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases). I-Intervention: Intake of foods (capsules, tablets, drinks, foods) containing salacinol. C-Control: Intake of a placebo that does not contain salacinol. O-Outcome: Suppressive effect on postprandial sugar absorption (Postprandial blood sugar value, blood sugar area under the curve (AUC) and blood insulin area under the curve (AUC))
Exclusion criteria
Exclusion criteria: Studies which do not meet the key inclusion criteria will be excluded. Intervention studies without a placebo intake group are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Suppressive effect on postprandial sugar absorption (Postprandial blood sugar value, blood sugar area under the curve (AUC) and blood insulin area under the curve (AUC)) | — |
Countries
Japan
Contacts
Public ContactYoshiyuki Shirakura
FUJIFILM Corporation Consumer Healthcare Business Div.
Outcome results
None listed